ATLASATLAS fair value
ATLAS has no fair value for this stock today.
GlaxoSmithKline Pakistan (GLAXO.KAR)
GlaxoSmithKline Pakistan stock price today, ATLAS forecast and fair value
Healthcare · Pharmaceuticals · Pakistan Stock Exchange · Pakistan
PKR 314.82▲ +2.44%
Prices as of Oct 27, 2026 · PKR
Chance of rising in 1 month
52%
that it ends higher than today in 21 sessions
0%coin flip 50%100%
This is just the summary. See everything on GlaxoSmithKline Pakistan in ATLAS
ATLAS's own quantitative analysis, all in one place.
- Simulation and expected rangeThousands of simulated scenarios: how far the price could rise or fall.
- Officers and shareholdersWho runs the company and which funds hold its shares.
- Customer and supplier mapWho it does business with, from its own filings.
- ATLAS builds your portfolioAnswer a short test and get portfolios that fit you.
- AlertsWe let you know when something changes in your stocks.
See everything included
- Valuation and financialsFair value step by step, quarterly accounts and upcoming events.
- NewsThe latest on the company, in one place.
- Crisis simulatorHow your portfolio would do in a crash like 2008.
- Practice risk-free$10,000 in virtual money to invest at real prices.
- Global screenerSearch US stocks and stocks from 47 countries with filters.
On GlaxoSmithKline Pakistan
- Simulation and expected rangeThousands of simulated scenarios: how far the price could rise or fall.
- Officers and shareholdersWho runs the company and which funds hold its shares.
- Customer and supplier mapWho it does business with, from its own filings.
- Valuation and financialsFair value step by step, quarterly accounts and upcoming events.
- NewsThe latest on the company, in one place.
And for you
- ATLAS builds your portfolioAnswer a short test and get portfolios that fit you.
- AlertsWe let you know when something changes in your stocks.
- Crisis simulatorHow your portfolio would do in a crash like 2008.
- Practice risk-free$10,000 in virtual money to invest at real prices.
- Global screenerSearch US stocks and stocks from 47 countries with filters.
Plans from €3.99 a month.
ATLAS's model gives GlaxoSmithKline Pakistan a 52% chance of finishing higher a month from now (21 trading sessions) than today: close to a coin flip.
In half of the simulated outcomes the price ends between PKR 302.74 and PKR 329.55; in 9 out of 10, between PKR 280.80 and PKR 355.30. Estimated annual volatility is 17%.
Price, last 12 months (weekly close)
Key numbers
- 52-week high
- PKR 459.27
- 52-week low
- PKR 293.09
- Operating margin
- 0.0%
- Net margin
- 0.0%
What this means
ATLAS does not publish a fair value for GLAXO.KAR right now, but it does show its odds of rising: close to a coin flip.
Over the last 52 weeks GLAXO.KAR has traded between PKR 293.09 and PKR 459.27. Today it is 31.5% below that high and 7% above its low.
Want to see everything about GlaxoSmithKline Pakistan?
Get started →Plans from €3.99 a month.
Comparable companies
Other companies in the same line of business:
Frequently asked questions
What is the chance GLAXO.KAR goes up next month?
52%: close to a coin flip. In half of the simulated outcomes, GLAXO.KAR ends the month between PKR 302.74 and PKR 329.55.
How volatile is GLAXO.KAR?
ATLAS estimates annual volatility at 17%. In a typical month, half of the outcomes end between PKR 302.74 and PKR 329.55.
Not investment advice. ATLAS estimates are produced by statistical models from public data; they can be wrong and past performance does not predict future results. Consider your own situation before investing. Disclaimer